ENDPOINTS NEWS32m
With $120M, GSK-al­lied Ouro Med­i­cines throws its hat in­to bur­geon­ing TCE ring
T cell engagers are having a moment, much like antibody-drug conjugates have for the past two years. The cell-depleting ...